栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/05/18 | 2,101 | 2,117 | 2,087 | 2,092 | +16 | +0.8% | 116,700 |
2021/05/17 | 2,107 | 2,136 | 2,076 | 2,076 | -21 | -1% | 100,400 |
2021/05/14 | 2,084 | 2,101 | 2,045 | 2,097 | +58 | +2.8% | 112,200 |
2021/05/13 | 2,054 | 2,075 | 2,036 | 2,039 | -55 | -2.6% | 110,100 |
2021/05/12 | 2,144 | 2,164 | 2,083 | 2,094 | -56 | -2.6% | 179,600 |
2021/05/11 | 2,187 | 2,199 | 2,146 | 2,150 | -60 | -2.7% | 135,700 |
2021/05/10 | 2,224 | 2,228 | 2,201 | 2,210 | -12 | -0.5% | 115,600 |
2021/05/07 | 2,233 | 2,244 | 2,202 | 2,222 | +13 | +0.6% | 171,700 |
2021/05/06 | 2,191 | 2,259 | 2,180 | 2,209 | +31 | +1.4% | 332,600 |
2021/04/30 | 2,230 | 2,230 | 2,167 | 2,178 | -26 | -1.2% | 391,800 |
2021/04/28 | 2,220 | 2,220 | 2,191 | 2,204 | -21 | -0.9% | 185,900 |
2021/04/27 | 2,198 | 2,243 | 2,181 | 2,225 | +24 | +1.1% | 176,400 |
2021/04/26 | 2,213 | 2,214 | 2,168 | 2,201 | -12 | -0.5% | 96,000 |
2021/04/23 | 2,214 | 2,233 | 2,199 | 2,213 | -23 | -1% | 122,400 |
2021/04/22 | 2,211 | 2,247 | 2,211 | 2,236 | +69 | +3.2% | 206,400 |
2021/04/21 | 2,210 | 2,215 | 2,145 | 2,167 | -51 | -2.3% | 216,900 |
2021/04/20 | 2,205 | 2,259 | 2,187 | 2,218 | -24 | -1.1% | 281,300 |
2021/04/19 | 2,195 | 2,247 | 2,193 | 2,242 | +80 | +3.7% | 291,000 |
2021/04/16 | 2,175 | 2,176 | 2,145 | 2,162 | -25 | -1.1% | 178,100 |
2021/04/15 | 2,176 | 2,205 | 2,169 | 2,187 | +111 | +5.3% | 318,400 |
2021/04/14 | 2,074 | 2,085 | 2,057 | 2,076 | +9 | +0.4% | 92,500 |
2021/04/13 | 2,073 | 2,099 | 2,066 | 2,067 | -11 | -0.5% | 113,000 |
2021/04/12 | 2,083 | 2,088 | 2,066 | 2,078 | +9 | +0.4% | 75,000 |
2021/04/09 | 2,070 | 2,085 | 2,053 | 2,069 | +8 | +0.4% | 122,600 |
2021/04/08 | 2,098 | 2,104 | 2,061 | 2,061 | -53 | -2.5% | 145,600 |
2021/04/07 | 2,117 | 2,138 | 2,101 | 2,114 | +17 | +0.8% | 115,600 |
2021/04/06 | 2,165 | 2,165 | 2,097 | 2,097 | -74 | -3.4% | 134,700 |
2021/04/05 | 2,205 | 2,217 | 2,166 | 2,171 | -19 | -0.9% | 73,200 |
2021/04/02 | 2,224 | 2,227 | 2,187 | 2,190 | -34 | -1.5% | 82,000 |
2021/04/01 | 2,207 | 2,252 | 2,200 | 2,224 | +61 | +2.8% | 305,100 |
2021/03/31 | 2,138 | 2,178 | 2,138 | 2,163 | +8 | +0.4% | 130,800 |
2021/03/30 | 2,174 | 2,176 | 2,124 | 2,155 | -18 | -0.8% | 131,400 |
2021/03/29 | 2,167 | 2,191 | 2,149 | 2,173 | +8 | +0.4% | 166,900 |
2021/03/26 | 2,146 | 2,176 | 2,138 | 2,165 | +26 | +1.2% | 157,400 |
2021/03/25 | 2,132 | 2,158 | 2,120 | 2,139 | +7 | +0.3% | 138,800 |
2021/03/24 | 2,172 | 2,172 | 2,118 | 2,132 | -53 | -2.4% | 128,600 |
2021/03/23 | 2,200 | 2,220 | 2,183 | 2,185 | -4 | -0.2% | 162,500 |
2021/03/22 | 2,200 | 2,205 | 2,177 | 2,189 | +10 | +0.5% | 158,600 |
2021/03/19 | 2,164 | 2,181 | 2,141 | 2,179 | -8 | -0.4% | 148,200 |
2021/03/18 | 2,195 | 2,202 | 2,171 | 2,187 | +27 | +1.3% | 264,500 |
2021/03/17 | 2,110 | 2,160 | 2,103 | 2,160 | +54 | +2.6% | 176,800 |
2021/03/16 | 2,104 | 2,109 | 2,081 | 2,106 | +7 | +0.3% | 113,300 |
2021/03/15 | 2,092 | 2,099 | 2,061 | 2,099 | +14 | +0.7% | 150,000 |
2021/03/12 | 2,090 | 2,090 | 2,065 | 2,085 | -20 | -1% | 154,300 |
2021/03/11 | 2,103 | 2,112 | 2,090 | 2,105 | +2 | +0.1% | 128,400 |
2021/03/10 | 2,104 | 2,122 | 2,095 | 2,103 | +6 | +0.3% | 165,300 |
2021/03/09 | 2,100 | 2,100 | 2,063 | 2,097 | +14 | +0.7% | 101,100 |
2021/03/08 | 2,093 | 2,107 | 2,066 | 2,083 | -2 | -0.1% | 157,500 |
2021/03/05 | 2,055 | 2,085 | 2,041 | 2,085 | +24 | +1.2% | 206,300 |
2021/03/04 | 2,074 | 2,074 | 2,037 | 2,061 | -4 | -0.2% | 182,700 |
851~
900
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム